{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:40:08Z","timestamp":1778956808394,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.jdermsci.2007.12.004","type":"journal-article","created":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T12:21:32Z","timestamp":1203510092000},"page":"217-225","source":"Crossref","is-referenced-by-count":21,"title":["Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-\u03b3 and narrowband UVB in patients with mycosis fungoides"],"prefix":"10.1016","volume":"50","author":[{"given":"Takatoshi","family":"Shimauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideka","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Tokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2007.12.004_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2559.1992.tb00343.x","article-title":"Differential expression of the HECA-452 antigen (cutaneous lymphocyte-associated antigen, CLA) in cutaneous and non-cutaneous T-cell lymphomas","volume":"21","author":"Noorduyn","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1523-1747.ep12363378","article-title":"The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens","volume":"107","author":"Berger","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1998.00599.x","article-title":"Tumor-specific cytotoxic T lymphocyte activity in Th2-type Sezary syndrome: its enhancement by interferon-\u03b3 (IFN-\u03b3) and IL-12 and fluctuations in association with disease activity","volume":"112","author":"Seo","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2336\/nishinihonhifu.51.766","article-title":"Phase II study of recombinant human interferon \u03b3 (SUN4800) for cutaneous malignancies","volume":"51","author":"Ishihara","year":"1989","journal-title":"Nishinihon Hifuka"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jnci\/82.3.208","article-title":"Phase II study of recombinant human interferon \u03b3 for treatment of cutaneous T-cell lymphoma","volume":"82","author":"Kaplan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1523-1747.ep12520022","article-title":"Action spectrum for phototherapy of psoriasis","volume":"76","author":"Parrish","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mjd.2002.120911","article-title":"Narrowband UVB phototherapy for early-stage mycosis fungoides","volume":"47","author":"Gathers","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1067\/mjd.2003.80","article-title":"Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study","volume":"48","author":"Diederen","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1523-1747.2000.00115.x","article-title":"A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin","volume":"115","author":"Vestergaard","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1023\/A:1021948214742","article-title":"Production of TARC and MDC by na\u00efve T cells in asthmatic patients","volume":"23","author":"Hirata","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib13","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib14","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","article-title":"Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4","volume":"273","author":"Imai","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes","volume":"187","author":"Sallusto","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib16","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes","volume":"184","author":"Loetscher","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1046\/j.1523-1747.2003.12555.x","article-title":"Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides","volume":"121","author":"Kallinich","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib21","first-page":"553","article-title":"The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2- associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia\/lymphoma","volume":"13","author":"Yamaguchi","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","article-title":"The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides","volume":"115","author":"Lu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jaad.2006.02.012","article-title":"CXCR3 and CCR4 double positive tumor cells in granulomatous mycosis fungoides","volume":"54","author":"Shimauchi","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.pas.0000213267.92349.59","article-title":"Chemokine receptor expression in cutaneous T cell and NK\/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay","volume":"30","author":"Yagi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jdermsci.2005.01.005","article-title":"Treatment with IFN-\u03b3 increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides","volume":"38","author":"Hino","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2133.2007.07774.x","article-title":"Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes","volume":"156","author":"Hino","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI200524826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archderm.136.6.748","article-title":"Narrowband TL-01 phototherapy for patch-stage mycosis fungoides","volume":"136","author":"Clark","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2133.2003.05224.x","article-title":"The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sezary syndrome","volume":"148","author":"Papadavid","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1523-1747.1998.00263.x","article-title":"Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas","volume":"111","author":"Tensen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2007.12.004_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2230.2006.02261.x","article-title":"Sezary syndrome treated with narrowband ultraviolet B: time-course measurement of serum levels of CCL17\/27","volume":"32","author":"Masui","year":"2007","journal-title":"Clin Exp Dermatol"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181107004136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181107004136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T10:22:48Z","timestamp":1546251768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181107004136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0923181107004136"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2007.12.004","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}